Celebrating ‘quiet greatness,’ Cornell Tech dedicates Feeney Way

Cornell celebrated the life of Charles F. “Chuck” Feeney ’56, founding chairman of The Atlantic Philanthropies, during an event April 19 at Cornell Tech to commemorate the university’s most generous donor and officially name the main thoroughfare of the New York City campus in his honor.

Immunologist receives biomedical research award

Ashley Nelson, assistant professor of immunology research in the Department of Pediatrics at Weill Cornell Medicine, has received a 2023 Hartwell Individual Biomedical Research Award from The Hartwell Foundation.

Chen, Ryan, Wolfner elected to arts and sciences academy

Professors Peng Chen, Mariana Wolfner ’74 and Timothy A. Ryan, M.S. ’86, Ph.D. ’89, have been elected to the American Academy of Arts and Sciences, the academy announced on April 24.

As Empire AI dawns, Cornell lays groundwork for public good

Empire AI, a $400 million effort to create a shared academic research computing facility, is set to advance dozens of ambitious, cross-disciplinary projects at Cornell.

Tracking a protein’s fleeting shape changes

Researchers at Weill Cornell Medicine have developed a powerful new technique to generate “movies” of changing protein structures at speeds of up to 50 frames per second. 

Anemia linked to higher female mortality during heart surgery

Women are at higher risk of death when undergoing heart bypass surgery than men, and researchers have determined that this disparity is mediated, to a large extent, by the loss of red blood cells during surgery. 

New atlas of mRNA variants captures inner workings of brain

Investigators at Weill Cornell Medicine have assembled the most comprehensive atlas to date of messenger RNA variants in the mouse and human brain, helping neuroscientists understand how the brain develops and functions.

Nasal spray can safely treat recurrent abnormal heart rhythms

A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms.

Neuron model paves way for new Alzheimer’s therapies

Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain – a process that drives cognitive decline in Alzheimer’s disease and frontotemporal dementia.